/ Home
/ SUBMISSION

/ The BJOC
/ Diamond Open Access
/ Journal Statistics
/ Editorial Board
/ Community
/ Call for papers

/ Latest Articles
/ Most accessed
/ Thematic issues
/ Volumes
/ Authors

/ Alerts

/ TWITTER
/ LINKEDIN
/ Mastodon
/ RSS FEED

Empty search

Article Type

Publication Date Range

Search Tips

This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.

Search Examples

aromatic	the word “aromatic”
aromatic aldehyde	the word “aromatic” OR “aldehyde”
+aromatic +aldehyde	both words “aromatic” AND “aldehyde”
+aromatic -aldehyde	the word “aromatic” but NOT “aldehyde”
“aromatic aldehyde”	the exact phrase “aromatic aldehyde”
benz*	words which begin with “benz”, such as “benzene” or “benzyl”
benz*yl	words that begin with “benz” and end with “yl”, such as “benzyl” or “benzoyl”
benzyl~	words that are close to the word “benzyl”, such as “benzoyl” (i.e., fuzzy search)

Search results

Search for "combretastatin D" in Full Text gives 1 result(s) in Beilstein Journal of Organic Chemistry.

Combretastatins D series and analogues: from isolation, synthetic challenges and biological activities

Jorge de Lima Neto and
Paulo Henrique Menezes

Beilstein J. Org. Chem. 2023, 19, 399–427, doi:10.3762/bjoc.19.31

Jorge de Lima Neto Paulo Henrique Menezes Universidade Federal de Pernambuco, Departamento de Química Fundamental, Recife-PE, 50740-560, Brazil 10.3762/bjoc.19.31 Abstract The combretastatin D series and its analogues, corniculatolides and isocorniculatolides belong to a class of macrocycles

called cyclic diaryl ether heptanoids (DAEH). This review is intended to highlight the structure elucidation, biosynthesis, and biological activity of these compounds as well as the use of different strategies for their synthesis. Keywords: combretastatin D; corniculatolide; isocorniculatolide

stereochemical characteristics, but also for shown biological activities, with potential therapeutic application [6][7][8][9][10][11][12]. Examples of this class of compounds are the combretastatin D series [13] and their analogues, corniculatolides and isocorniculatolides [14], which are structurally

PDF

Graphical Abstract

Figure 1: Structures of some members of the combretastatin D series, corniculatolides, and isocorniculatolide...

Jump to Figure 1

Scheme 1: Biosynthetic pathway proposed by Pettit and co-workers.

Jump to Scheme 1

Scheme 2: Biosynthetic pathway towards corniculatolides or isocorniculatolides proposed by Ponnapalli and co-...

Jump to Scheme 2

Scheme 3: Retrosynthetic approaches.

Jump to Scheme 3

Scheme 4: Attempt of total synthesis of 2 by Boger and co-workers employing the Mitsunobu approach [27].

Jump to Scheme 4

Scheme 5: Total synthesis of combretastatin D-2 (2) reported by Boger and co-workers employing an intramolecu...

Jump to Scheme 5

Scheme 6: Formal synthesis of combretastatin D-2 (2) by Deshpande and co-workers using the Mitsunobu conditio...

Jump to Scheme 6

Scheme 7: Total synthesis of combretastatin D-2 (2) by Rychnovsky and Hwang [36].

Jump to Scheme 7

Scheme 8: Divergent synthesis of (±)-1 form combretastatin D-2 (2) by Rychnovsky and Hwang [36].

Jump to Scheme 8

Scheme 9: Enantioselective synthesis of 1 by Rychnovsky and Hwang employing Jacobsen catalyst [41].

Jump to Scheme 9

Scheme 10: Synthesis of fragment 57 by Couladouros and co-workers [43,45].

Jump to Scheme 10

Scheme 11: Formal synthesis of compound 2 by Couladouros and co-workers [43,45].

Jump to Scheme 11

Scheme 12: Synthesis of fragment 66 by Couladouros and co-workers [44,45].

Jump to Scheme 12

Scheme 13: Synthesis of fragment 70 by Couladouros and co-workers [44,45].

Jump to Scheme 13

Scheme 14: Synthesis of fragment 77 by Couladouros and co-workers [44,45].

Jump to Scheme 14

Scheme 15: Synthesis of combretastatins 1 and 2 by Couladouros and co-workers [44,45].

Jump to Scheme 15

Scheme 16: Formal synthesis of compound 2 by Gangakhedkar and co-workers [48].

Jump to Scheme 16

Scheme 17: Synthesis of fragment 14 by Cousin and co-workers [50].

Jump to Scheme 17

Scheme 18: Synthesis of fragment 91 by Cousin and co-workers [50].

Jump to Scheme 18

Scheme 19: Formal synthesis of compound 2 by Cousin and co-workers [50].

Jump to Scheme 19

Scheme 20: Synthesis of 2 diolide by Cousin and co-workers [50].

Jump to Scheme 20

Scheme 21: Synthesis of combretastatin D-4 (4) by Nishiyama and co-workers [54].

Jump to Scheme 21

Scheme 22: Synthesis of fragment 112 by Pettit and co-workers [55].

Jump to Scheme 22

Scheme 23: Synthesis of fragment 114 by Pettit and co-workers [55].

Jump to Scheme 23

Scheme 24: Attempt to the synthesis of compound 2 by Pettit and co-workers [55].

Jump to Scheme 24

Scheme 25: Synthesis of combretastatin-D2 (2) starting from isovanilin (80) by Pettit and co-workers [55].

Jump to Scheme 25

Scheme 26: Attempted synthesis of combretastatin-D2 (2) derivatives through an S_NAr approach [55].

Jump to Scheme 26

Scheme 27: Synthesis of combretastatin D-4 (4) by Pettit and co-workers [55].

Jump to Scheme 27

Scheme 28: Synthesis of combretastatin D-2 (2) by Harras and co-workers [57].

Jump to Scheme 28

Scheme 29: Synthesis of combretastatin D-4 (4) by Harras and co-workers [57].

Jump to Scheme 29

Scheme 30: Formal synthesis of combretastatin D-1 (1) by Harras and co-workers [57].

Jump to Scheme 30

Scheme 31: Synthesis of 11-O-methylcorniculatolide A (5) by Raut and co-workers [69].

Jump to Scheme 31

Scheme 32: Synthesis of isocorniculatolide A (7) and O-methylated isocorniculatolide A 8 by Raut and co-worker...

Jump to Scheme 32

Scheme 33: Synthesis of isocorniculatolide B (10) and hydroxyisocorniculatolide B 175 by Kim and co-workers [71].

Jump to Scheme 33

Scheme 34: Synthesis of compound 9, 178, and 11 by Kim and co-workers [71].

Jump to Scheme 34

Scheme 35: Synthesis of combretastatin D-2 prodrug salts [55].

Jump to Scheme 35

Figure 2: ED₅₀ values of the combretastatin D family against murine P388 lymphocytic leukemia cell line (appr...

Jump to Figure 2

Figure 3: IC₅₀ of compounds against α-glucosidase [19].

Jump to Figure 3

Album

Review

Published 29 Mar 2023

Full text

Other Beilstein-Institut Open Science Activities

/ Help / Support & Contact / Alerts / Privacy Policy / Terms & Conditions / Impressum